Spots Global Cancer Trial Database for os
Every month we try and update this database with for os cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Next-generation Sequencing in Gastrointestinal Cancer | NCT03476057 | Gastrointestina... | Device： NGS seq... | - | Fujian Cancer Hospital | |
| Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma | NCT03376958 | Relapsed and Re... Diffuse Large B... | Apatinib | 14 Years - 70 Years | Zhengzhou University | |
| Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy. | NCT04642469 | Carcinoma, Non-... | Durvalumab Placebo | 18 Years - 130 Years | AstraZeneca | |
| Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) | NCT05520138 | Prostatic Neopl... | Enzalutamide Abiraterone ace... | 18 Years - | Pfizer | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma | NCT03513601 | Diffuse Large B... | (R)-CHOP regime... (R)-CVP regimen | 70 Years - 85 Years | Zhengzhou University | |
| A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients | NCT03706690 | Carcinoma, Non-... | Durvalumab Placebo | 18 Years - 130 Years | AstraZeneca | |
| Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System | NCT01565486 | Thyroid Cancer | Ultrasonic coag... bipolar energy ... | 20 Years - 80 Years | Seoul St. Mary's Hospital | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma | NCT03168607 | Neuroendocrine ... | FOLFIRI Protoco... | 18 Years - | Peking University | |
| Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer | NCT02629718 | PFS OS Quality of Life | NACT (Paclitaxe... radical surgery | 18 Years - 65 Years | Sun Yat-sen University | |
| Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma | NCT04083066 | Primary Central... | rituximab in co... | 14 Years - 75 Years | Zhengzhou University | |
| Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) | NCT03003962 | Non Small Cell ... | Durvalumab (MED... Paclitaxel + ca... Gemcitabine + c... Gemcitabine + c... Pemetrexed + ci... Pemetrexed + ca... | 18 Years - 130 Years | AstraZeneca | |
| Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor | NCT03279601 | Neuroendocrine ... | Capecitabine, D... Capecitabine, T... | 18 Years - | Peking University | |
| Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma | NCT03376958 | Relapsed and Re... Diffuse Large B... | Apatinib | 14 Years - 70 Years | Zhengzhou University | |
| Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients / Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation | NCT03833154 | Carcinoma, Non-... | Durvalumab Placebo Osimertinib (si... | 18 Years - 130 Years | AstraZeneca | |
| Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer | NCT04431791 | Colorectal Canc... | Regorafenib Fruquintinib | - | Peking University | |
| Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients / Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation | NCT03833154 | Carcinoma, Non-... | Durvalumab Placebo Osimertinib (si... | 18 Years - 130 Years | AstraZeneca | |
| A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients | NCT03706690 | Carcinoma, Non-... | Durvalumab Placebo | 18 Years - 130 Years | AstraZeneca | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection | NCT01534546 | Advanced Gastri... | Oxaliplatin cap... Oxaliplatin S-1 Oxaliplatin S-1 | 18 Years - | Peking University | |
| Treatment of Primary CNS Lymphoma ( FTD ) | NCT05274139 | Primary CNS Lym... | HD-MTX-Ara-C re... FTD regimen | 14 Years - 69 Years | Zhengzhou University | |
| Next-generation Sequencing in Gastrointestinal Cancer | NCT03476057 | Gastrointestina... | Device： NGS seq... | - | Fujian Cancer Hospital | |
| A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients | NCT01793844 | Diffuse Large B... | 18 Years - 70 Years | Sun Yat-sen University | ||
| Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma | NCT03168594 | Neuroendocrine ... | irinotecan cisp... Etoposide cispl... | 18 Years - | Peking University | |
| Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) | NCT02542293 | Non Small Cell ... | Durvalumab +Tre... Paclitaxel + ca... Gemcitabine + c... Gemcitabine + c... Pemetrexed + ci... Pemetrexed + ca... | 18 Years - 130 Years | AstraZeneca | |
| Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection | NCT01534546 | Advanced Gastri... | Oxaliplatin cap... Oxaliplatin S-1 Oxaliplatin S-1 | 18 Years - | Peking University | |
| A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients | NCT01793844 | Diffuse Large B... | 18 Years - 70 Years | Sun Yat-sen University | ||
| Treatment of Primary CNS Lymphoma ( FTD ) | NCT05274139 | Primary CNS Lym... | HD-MTX-Ara-C re... FTD regimen | 14 Years - 69 Years | Zhengzhou University | |
| Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer | NCT03528694 | Non-muscle-inva... | Durvalumab (MED... Bacillus Calmet... | 18 Years - 130 Years | AstraZeneca | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) | NCT02542293 | Non Small Cell ... | Durvalumab +Tre... Paclitaxel + ca... Gemcitabine + c... Gemcitabine + c... Pemetrexed + ci... Pemetrexed + ca... | 18 Years - 130 Years | AstraZeneca | |
| A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer | NCT05968599 | Prostatic Neopl... | Enzalutamide Abiraterone ace... | 18 Years - | Pfizer | |
| SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer | NCT01811277 | Biliary Tract C... Periampullary A... Pancreatic Canc... | SOX sequential ... | 18 Years - 75 Years | Peking University | |
| The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer. | NCT05749887 | Cervical Cancer | salvage surgery | 18 Years - 70 Years | Chongqing University Cancer Hospital | |
| Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) | NCT05520138 | Prostatic Neopl... | Enzalutamide Abiraterone ace... | 18 Years - | Pfizer | |
| Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL | NCT03707847 | ALK-Positive An... | Crizotinib Etoposide Capsu... Auto-HSCT | 14 Years - 65 Years | Zhengzhou University | |
| A Prospective Clinical Study for Laparoscopic D3 Dissection With Preservation of Left Colic Artery in Rectal Cancer | NCT02753465 | Rectal Neoplasm... | left colic arte... High ligation | 18 Years - 80 Years | Fudan University | |
| Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) | NCT03003962 | Non Small Cell ... | Durvalumab (MED... Paclitaxel + ca... Gemcitabine + c... Gemcitabine + c... Pemetrexed + ci... Pemetrexed + ca... | 18 Years - 130 Years | AstraZeneca | |
| Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma | NCT03513601 | Diffuse Large B... | (R)-CHOP regime... (R)-CVP regimen | 70 Years - 85 Years | Zhengzhou University | |
| A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma | NCT04831658 | Primary Central... | the dose-escala... | 18 Years - 69 Years | Zhengzhou University | |
| A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM) | NCT02586857 | Glioblastoma Mu... | ACP-196 | - | Acerta Pharma BV | |
| A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma | NCT04831658 | Primary Central... | the dose-escala... | 18 Years - 69 Years | Zhengzhou University | |
| Treatment of Primary CNS Lymphoma ( FTD ) | NCT05274139 | Primary CNS Lym... | HD-MTX-Ara-C re... FTD regimen | 14 Years - 69 Years | Zhengzhou University | |
| Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma | NCT03513601 | Diffuse Large B... | (R)-CHOP regime... (R)-CVP regimen | 70 Years - 85 Years | Zhengzhou University | |
| Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor | NCT03279601 | Neuroendocrine ... | Capecitabine, D... Capecitabine, T... | 18 Years - | Peking University | |
| A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma | NCT03579082 | Diffuse Large B... | Decitabine | 14 Years - 65 Years | Zhengzhou University | |
| Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection | NCT01534546 | Advanced Gastri... | Oxaliplatin cap... Oxaliplatin S-1 Oxaliplatin S-1 | 18 Years - | Peking University | |
| Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) | NCT05520138 | Prostatic Neopl... | Enzalutamide Abiraterone ace... | 18 Years - | Pfizer | |
| Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer | NCT03243838 | Triple-Negative... | Apatinib | 18 Years - 70 Years | Guangdong Provincial People's Hospital | |
| Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer | NCT03243838 | Triple-Negative... | Apatinib | 18 Years - 70 Years | Guangdong Provincial People's Hospital | |
| Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System | NCT01565486 | Thyroid Cancer | Ultrasonic coag... bipolar energy ... | 20 Years - 80 Years | Seoul St. Mary's Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
